Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy.

Cardiovasc Interv Ther · 2022 · PMC8926957 · PMID 33813727

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

failed to reach statistical significancep = 0.054so close (0.05 < p ≤ 0.1)

Three factors with at least a 0.2 probability were selected in the ANCOVA model yet failed to reach statistical significance, namely age ≥ 65 ( p = 0.054), diabetic status ( p = 0.091), and BMI < 25 ( p = 0.136).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.